We are live on
!
Find out more
Lineage Cell Therapeutics
LCTX
LCTX
58 hedge funds and large institutions have $57.6M invested in Lineage Cell Therapeutics in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
54% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 13
1.14% more ownership
Funds ownership: 31.19% → 32.33% (+1.1%)
0% more funds holding
Funds holding: 58 → 58 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
5% less capital invested
Capital invested by funds: $60.8M → $57.6M (-$3.22M)
82% less call options, than puts
Call options by funds: $27K | Put options by funds: $152K
Holders
58
Holders Change
–
Holders Change %
0%
% of All Funds
1.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
20
Reduced
13
Closed
6
Calls
$27K
Puts
$152K
Net Calls
-$125K
Net Calls Change
+$250K
Top Buyers
| 1 |
BC
Broadwood Capital
New York
|
+$1.82M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$787K |
| 3 |
Morgan Stanley
New York
|
+$577K |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$446K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$374K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.21M |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$255K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$132K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$130K |
| 5 |
D.E. Shaw & Co
New York
|
-$104K |
